pharma · Obese · Hyperlipemia
Suzhou Ribo Life
Suzhou Ribo Life Science Co.
Suzhou Ribo Life is a pharma organization headquartered in CN. Primary therapeutic focus areas include Obese, Hyperlipemia, Non-small Cell Lung Cancer, Rheumatoid Arthritis (RA). NovaPharmaNews links 4 clinical program(s
Beijing, CN HQ
2007 Founded
32 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Beijing, CN
- Founded
- 2007
- Employees
- 32
- Programs
- 4
- Drugs
- 7
- Patents
- 0
RBD7022
Phase 1 · small molecule · Hyperlipemia
RBD7022 for Hyperlipemia is a Phase 1 program (small_molecule) at Suzhou Ribo Life Science Co. with 1 ClinicalTrials.gov record(s).
Internal code RBD7022
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Suzhou Ribo Life Science Co.
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Hyperlipemia
- Status
- completed
- Trials
- 1